Envestnet Portfolio Solutions Inc. Has $2.01 Million Stock Holdings in CVS Health Corporation (NYSE:CVS)

Envestnet Portfolio Solutions Inc. lowered its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 41.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 29,646 shares of the pharmacy operator's stock after selling 20,563 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in CVS Health were worth $2,009,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Hopwood Financial Services Inc. bought a new position in CVS Health during the fourth quarter worth $29,000. McIlrath & Eck LLC raised its position in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after buying an additional 174 shares during the last quarter. Providence First Trust Co bought a new stake in shares of CVS Health in the fourth quarter valued at about $42,000. Park Square Financial Group LLC acquired a new stake in CVS Health during the fourth quarter worth about $43,000. Finally, PARK CIRCLE Co increased its stake in CVS Health by 42.9% during the fourth quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock valued at $45,000 after acquiring an additional 300 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Trading Down 0.2%

CVS opened at $66.69 on Monday. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51. The stock has a market capitalization of $84.36 billion, a PE ratio of 15.92, a PEG ratio of 0.95 and a beta of 0.56. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The firm has a 50-day moving average price of $64.92 and a two-hundred day moving average price of $60.45.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same quarter last year, the business posted $1.31 earnings per share. CVS Health's revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, equities analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Insider Activity

In other CVS Health news, Director Guy P. Sansone purchased 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director now directly owns 12,007 shares in the company, valued at approximately $764,845.90. This represents a 15.04% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. UBS Group raised their price objective on CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Mizuho raised their target price on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Truist Financial lifted their price target on shares of CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Monday, May 12th. Robert W. Baird increased their price objective on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.